Amgen (AMGN) Total Liabilities (2009 - 2026)

Amgen (AMGN) has reported Total Liabilities for 18 consecutive years, with $83.3 billion the latest figure, recorded in Q1 2026.

• In Q1 2026, Total Liabilities changed 0.19% year-over-year to $83.3 billion; the TTM figure through Mar 2026 stood at $83.3 billion (changed 0.19% YoY), while the FY2025 annual figure was $81.9 billion, down 4.69% from the prior year.
• Total Liabilities came in at $83.3 billion for Q1 2026 at Amgen, up from $81.9 billion in the prior quarter.
• The five-year high for Total Liabilities was $90.9 billion in Q4 2023, with the low at $56.9 billion in Q2 2022.
• Average Total Liabilities over 5 years is $78.2 billion, with a median of $83.2 billion recorded in 2025.
• Across the five-year window, Total Liabilities soared 47.94% in 2023 and slipped 5.46% in 2024, its largest moves.
• Year by year, Total Liabilities stood at $61.5 billion in 2022, then jumped by 47.94% to $90.9 billion in 2023, then declined by 5.46% to $86.0 billion in 2024, then fell by 4.69% to $81.9 billion in 2025, then advanced by 1.69% to $83.3 billion in 2026.
• According to Business Quant data, Total Liabilities over the past three periods registered $83.3 billion, $81.9 billion, and $80.5 billion for Q1 2026, Q4 2025, and Q3 2025 respectively.